China FDA Highlights Product Recalls, Manufacturers Urged To Make Rapid Responses
This article was originally published in PharmAsia News
Despite being one of the largest medical product markets in the world, China has seen few product recalls. The situation could be changing however as China FDA has requested drug and device manufacturers to quickly withdraw products that have deficiencies and potential safety risks.
You may also be interested in...
J&J Consumer Business Picks Up, But Analysts See Long Road
The consumer business inched up 1% operationally in Q3, including about 6% growth at constant currency in OTC/nutritionals. However, costs associated with the remediation of McNeil OTC facilities are expected to weigh on J&J through most of 2013.
China Passes Food Safety Law Following Melamine Infant Formula Disasters
SHANGHAI - China's top legislature passed the long-awaited Food Safety Law in response to a national call for stricter food safety following the Sanlu dairy melamine incident, which led to the deaths of six infants last year (PharmAsia News, Jan. 5, 2009)
China Micron Ban Not Cause For Further Health Sector Worry?
China has taken a new counterstrike against the US in the chips sector, but the risk of potential wider impact on the biopharma sector appears to be limited given other tighter regulations already in place.